Company · CIK 1538210
NexImmune, Inc.
| CIK | 1538210 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MD |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-03-31 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-263399 | 2022-03-09 | 2024-08-28 | 6 | |
| 333-252220 | 2021-01-19 | 2021-02-16 | 5 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-08-28 | EFFECTDeclared effective | 333-263399 | 9999999995-24-002655 |
| 2024-02-05 | 424B5Shelf takedown | 333-263399 | 0001193125-24-024111 |
| 2023-04-07 | 424B5Shelf takedown | 333-263399 | 0001193125-23-095294 |
| 2022-06-17 | 424B5Shelf takedown | 333-263399 | 0001193125-22-176590 |
| 2022-03-16 | EFFECTDeclared effective | 333-263399 | 9999999995-22-000658 |
| 2022-03-09 | S-3Shelf registered | 333-263399 | 0001193125-22-070714 |
| 2021-02-16 | 424B4Final prospectus | 333-252220 | 0001193125-21-045015 |
| 2021-02-11 | EFFECTDeclared effective | 333-252220 | 9999999995-21-000597 |
| 2021-02-11 | S-1/AAmendment | 333-252220 | 0001193125-21-037480 |
| 2021-02-08 | S-1/AAmendment | 333-252220 | 0001193125-21-031549 |
| 2021-01-19 | S-1Registration filed | 333-252220 | 0001193125-21-011521 |
| 2020-12-14 | DRSDraft made public | 377-03882 | 0000950123-20-012609 |